Article

The CHARTER-Ireland trial: Can nebulised heparin reduce acute lung injury in patients with…

Research square · 2022 · John Robert Sheehan, author Padraig Caplin, author Siobhain Casey, author Maeve Kernan, author Claire Kelly, author Darragh Murphy, author Alberto Alvarez-Iglesias, author Camilla Giacomini, author Catriona Cody, author Shane McGeary, author Ciara Hanley, author Gerard Curley, author Frank Van Haren, author Bairbre McNicolas, author John G. Laffey, author David Cosgrave, author

Key facts

Title The CHARTER-Ireland trial: Can nebulised heparin reduce acute lung injury in patients with SARS-CoV-2 requiring advanced respiratory support in Ireland: a study protocol and statistical analysis plan for a randomised control trial
First author John Robert Sheehan, author Padraig Caplin, author Siobhain Casey, author Maeve Kernan, author Claire Kelly, author Darragh Murphy, author Alberto Alvarez-Iglesias, author Camilla Giacomini, author Catriona Cody, author Shane McGeary, author Ciara Hanley, author Gerard Curley, author Frank Van Haren, author Bairbre McNicolas, author John G. Laffey, author David Cosgrave, author
Journal Research square
Published Feb 16, 2022
DOI 10.21203/rs.3.rs-1280983/v1
Devices mentioned K070642
Product codes mentioned CAF

At a glance

  • 1–9 FDA submissions mentioned
  • 1–9 Product codes mentioned

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About Literature

Peer-reviewed and preprint literature indexed by Orca1 and linked to the FDA submissions and product codes each article mentions. Only bibliographic details are shown here.

Source: Publisher and PubMed metadata; device mentions identified by Orca1

Browse all Literature